The management of cardiac tamponade in patients with breast cancer.
Six patients with disseminated breast cancer and cardiac tamponade were treated with a pleuropericardial window and in four patients with systemic chemotherapy. The median survival of these six patients was 17 months (range 1-50 months). These results indicate that aggressive therapy in patients with cardiac tamponade and breast cancer can lead to prolonged survivals.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D002305:Cardiac Tamponade / Q000209:etiology / Q000628:therapy*; D005260:Female; D006338:Heart Neoplasms / Q000150:complications / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D010496:Pericardium / Q000601:surgery*